Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.

@article{Carr2004AbdominalOA,
  title={Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.},
  author={Molly C. Carr and John D. Brunzell},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2004},
  volume={89 6},
  pages={2601-7}
}
Regional body fat distribution has an important influence on metabolic and cardiovascular risk factors. Increased abdominal (visceral) fat accumulation is a risk factor for coronary artery disease (CAD), dyslipidemia, hypertension, stroke, and type 2 diabetes. The recent emphasis on treatment of the dyslipidemia of the metabolic syndrome (hypertriglyceridemia, reduced high-density lipoprotein, and increased small, dense low-density lipoprotein particle number) has compelled practitioners to… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 151 extracted citations

Similar Papers

Loading similar papers…